These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 23961878)
41. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Hoshino K; Sugiyama T; Matsumoto M; Tanaka T; Saito M; Hemmi H; Ohara O; Akira S; Kaisho T Nature; 2006 Apr; 440(7086):949-53. PubMed ID: 16612387 [TBL] [Abstract][Full Text] [Related]
42. Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Diebold SS; Massacrier C; Akira S; Paturel C; Morel Y; Reis e Sousa C Eur J Immunol; 2006 Dec; 36(12):3256-67. PubMed ID: 17111347 [TBL] [Abstract][Full Text] [Related]
43. Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer. Hirsch I; Caux C; Hasan U; Bendriss-Vermare N; Olive D Trends Immunol; 2010 Oct; 31(10):391-7. PubMed ID: 20832362 [TBL] [Abstract][Full Text] [Related]
44. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B. Chen Y; Li X; Ye B; Yang X; Wu W; Chen B; Pan X; Cao H; Li L Antiviral Res; 2011 Jul; 91(1):23-31. PubMed ID: 21549152 [TBL] [Abstract][Full Text] [Related]
45. Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future. Férir G; Kaptein S; Neyts J; De Clercq E Rev Med Virol; 2008; 18(1):19-34. PubMed ID: 17966115 [TBL] [Abstract][Full Text] [Related]
46. Synthesis and in vitro evaluation of 2-amino-4-N-piperazinyl-6-(3,4-dimethoxyphenyl)-pteridines as dual immunosuppressive and anti-inflammatory agents. De Jonghe S; Marchand A; Gao LJ; Calleja A; Cuveliers E; Sienaert I; Herman J; Clydesdale G; Sefrioui H; Lin Y; Pfleiderer W; Waer M; Herdewijn P Bioorg Med Chem Lett; 2011 Jan; 21(1):145-9. PubMed ID: 21131199 [TBL] [Abstract][Full Text] [Related]
47. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha. Ghosh TK; Mickelson DJ; Solberg JC; Lipson KE; Inglefield JR; Alkan SS Int Immunopharmacol; 2007 Aug; 7(8):1111-21. PubMed ID: 17570328 [TBL] [Abstract][Full Text] [Related]
48. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219 [TBL] [Abstract][Full Text] [Related]
49. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241 [TBL] [Abstract][Full Text] [Related]
50. An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression. Becker OM; Dhanoa DS; Marantz Y; Chen D; Shacham S; Cheruku S; Heifetz A; Mohanty P; Fichman M; Sharadendu A; Nudelman R; Kauffman M; Noiman S J Med Chem; 2006 Jun; 49(11):3116-35. PubMed ID: 16722631 [TBL] [Abstract][Full Text] [Related]
52. Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection. Carroll MB; Bond MI Semin Arthritis Rheum; 2008 Dec; 38(3):208-17. PubMed ID: 18221983 [TBL] [Abstract][Full Text] [Related]
53. Synthetic agonists of Toll-like receptors 7, 8 and 9. Agrawal S; Kandimalla ER Biochem Soc Trans; 2007 Dec; 35(Pt 6):1461-7. PubMed ID: 18031246 [TBL] [Abstract][Full Text] [Related]
54. The incidence and significance of pattern-recognition receptors in chronic viral hepatitis types B and C in man. Mozer-Lisewska I; Sikora J; Kowala-Piaskowska A; Kaczmarek M; Dworacki G; Zeromski J Arch Immunol Ther Exp (Warsz); 2010 Aug; 58(4):295-302. PubMed ID: 20533094 [TBL] [Abstract][Full Text] [Related]
55. Enhanced Delivery of TLR7/8 Agonists by Metal-Organic Frameworks for Hepatitis B Virus Cure. Wang L; Zhang G; Sun Y; Wu Z; Ren C; Zhang Z; Peng X; Zhang Y; Zhao Y; Li C; Gao L; Liang X; Sun H; Cui J; Ma C ACS Appl Mater Interfaces; 2022 Oct; 14(41):46176-46187. PubMed ID: 36206454 [TBL] [Abstract][Full Text] [Related]
56. Design, synthesis and biological evaluation of quinazoline and pyrrolo[3,2- Song Y; Fan W; Yao C; Wang H; Lu X; Wang Y; Liu P; Ma Y; Zhang Z; Wang J; Chu B; Shi L; Yang G; Wang M Org Biomol Chem; 2024 Apr; 22(14):2764-2773. PubMed ID: 38497199 [TBL] [Abstract][Full Text] [Related]
57. Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma. Biggadike K; Ahmed M; Ball DI; Coe DM; Dalmas Wilk DA; Edwards CD; Gibbon BH; Hardy CJ; Hermitage SA; Hessey JO; Hillegas AE; Hughes SC; Lazarides L; Lewell XQ; Lucas A; Mallett DN; Price MA; Priest FM; Quint DJ; Shah P; Sitaram A; Smith SA; Stocker R; Trivedi NA; Tsitoura DC; Weller V J Med Chem; 2016 Mar; 59(5):1711-26. PubMed ID: 26861551 [TBL] [Abstract][Full Text] [Related]
58. Fan H; Zhang A; Liao C; Yang Y; Zhang L; Liu J; Xia Y; Si D; Dong S; Liu C Xenobiotica; 2020 Apr; 50(4):468-478. PubMed ID: 31329010 [TBL] [Abstract][Full Text] [Related]